{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:59:56Z","timestamp":1768586396627,"version":"3.49.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1093\/rheumatology\/keu424","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T04:14:29Z","timestamp":1416024869000},"page":"981-993","source":"Crossref","is-referenced-by-count":24,"title":["Outcomes assessed in trials of gout and accordance with OMERACT-proposed domains: a systematic literature review"],"prefix":"10.1093","volume":"54","author":[{"given":"Filipe","family":"Ara\u00fajo","sequence":"first","affiliation":[]},{"given":"In\u00eas","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[]},{"given":"Louise","family":"Falzon","sequence":"additional","affiliation":[]},{"given":"Jaime C.","family":"Branco","sequence":"additional","affiliation":[]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"key":"key\n\t\t\t\t20170522164359_keu424-B1","first-page":"528","article-title":"OMERACT Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials: Introduction","volume":"20","author":"Tugwell","year":"1993","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B2","first-page":"2452","article-title":"Outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B3","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B4","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3899\/jrheum.090371","article-title":"Progress in measurement instruments for acute and chronic gout studies","volume":"36","author":"Grainger","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/ard.2007.079970","article-title":"A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout","volume":"67","author":"Taylor","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B6","first-page":"1381","article-title":"Outcome evaluations in gout","volume":"34","author":"Schumacher","year":"2007","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: An international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"key":"key\n\t\t\t\t20170522164359_keu424-B8","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins"},{"key":"key\n\t\t\t\t20170522164359_keu424-B9","volume-title":"Evidence-based medicine: how to practice and teach EBM","author":"Sackett","year":"1997"},{"key":"key\n\t\t\t\t20170522164359_keu424-B10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B11","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis","volume":"20","author":"Alloway","year":"1993","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B12","first-page":"1422","article-title":"Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study","volume":"15","author":"Altman","year":"1988","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.1985.tb05110.x","article-title":"Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis","volume":"20","author":"Butler","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0149-2918(04)90035-5","article-title":"A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis","volume":"26","author":"Cheng","year":"2004","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170522164359_keu424-B16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1142\/S0192415X95000316","article-title":"The anti-inflammatory and anti-hyperuricemic effects of Chinese herbal formula Danggui-Nian-Tong-Tang on acute gouty arthritis: a comparative study with indomethacin and allopurinol","volume":"23","author":"Chou","year":"1995","journal-title":"Am J Chin Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B17","first-page":"92","article-title":"A comparative, double-blind, parallel study with tenoxicam vs placebo in acute gouty arthritis","volume":"14","author":"Garcia de la Torre","year":"1987","journal-title":"Invest Med Int"},{"key":"key\n\t\t\t\t20170522164359_keu424-B18","first-page":"275","article-title":"A comparison of phenylbutazone and flufenamic acid in the treatment of acute gout","volume":"10","author":"Douglas","year":"1970","journal-title":"Ann Phys Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B19","first-page":"641","article-title":"Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study","volume":"33","author":"Eberl","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"key\n\t\t\t\t20170522164359_keu424-B20","first-page":"409","article-title":"Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricemia","volume":"37","author":"Fraser","year":"1987","journal-title":"J R Coll Gen Pract"},{"key":"key\n\t\t\t\t20170522164359_keu424-B21","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522164359_keu424-B22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02835742","article-title":"Effects of Rebixiao granules on blood uric acid in patients with repeatedly attacking acute gouty arthritis","volume":"11","author":"Ji","year":"2005","journal-title":"Chin J Integr Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B23","first-page":"540","article-title":"O tratamento da crise aguda de gota. Estudo duplo-cego, rand\u00f4mico, comparativo entre nimesulide e indometacina","volume":"53","author":"Klumb","year":"1996","journal-title":"Rev Bras Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B24","first-page":"344","article-title":"A double-blind comparison of Etodolac (Lodine) and high doses of naproxen in the treatment of acute gout","volume":"7","author":"Lederman","year":"1990","journal-title":"Adv Ther"},{"key":"key\n\t\t\t\t20170522164359_keu424-B25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(86)90131-2","article-title":"Flurbiprofen in the treatment of acute gout. A comparison with indomethacin","volume":"80","author":"Lomen","year":"1986","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","article-title":"Effectiveness of etodolac (\u2018Lodine\u2019) compared with naproxen in patients with acute gout","volume":"12","author":"Maccagno","year":"1991","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20170522164359_keu424-B27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","article-title":"Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial","volume":"49","author":"Man","year":"2007","journal-title":"Ann Emerg Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/030006058000800504","article-title":"Intravenous indoprofen for prompt relief of acute gout: a regimen-finding study","volume":"8","author":"Marcolongo","year":"1980","journal-title":"J Int Med Res"},{"key":"key\n\t\t\t\t20170522164359_keu424-B29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0254-6272(08)60023-0","article-title":"Treatment of 60 cases of gouty arthritis with modified Simiao tang","volume":"28","author":"Qiu","year":"2008","journal-title":"J Tradit Chin Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1185\/03007998009109465","article-title":"Double-blind trial of feprazone and phenylbutazone in acute gout","volume":"6","author":"Reardon","year":"1980","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20170522164359_keu424-B31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.20007","article-title":"Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial","volume":"50","author":"Rubin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B32","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis","volume":"29","author":"Schlesinger","year":"2002","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3297","article-title":"Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation: results of a randomized dose-ranging study","volume":"13","author":"Schlesinger","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20170522164359_keu424-B34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522164359_keu424-B35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0196-0644(95)70037-4","article-title":"Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis","volume":"26","author":"Shrestha","year":"1995","journal-title":"Ann Emerg Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11655-007-9001-7","article-title":"Randomized and controlled clinical study of modified prescriptions of Simiao-Pill in the treatment of acute gouty arthritis","volume":"14","author":"Shi","year":"2008","journal-title":"Chin J Integr Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B37","first-page":"1325","article-title":"Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis","volume":"21","author":"Siegel","year":"1994","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.32.4.351","article-title":"Comparison of indomethacin and phenylbutazone in acute gout","volume":"32","author":"Smyth","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B39","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.36.1.80","article-title":"Multicentre trial of naproxen and phenylbutazone in acute gout","volume":"36","author":"Sturge","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B41","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B42","first-page":"111","article-title":"Piroxicam in treatment of acute gout high dose versus low dose","volume":"68","author":"Tumrasvin","year":"1985","journal-title":"J Med Assoc Thai"},{"key":"key\n\t\t\t\t20170522164359_keu424-B43","first-page":"133","article-title":"Use of tenoxicam in patients with acute gouty arthritis","volume":"9","author":"Valdes","year":"1987","journal-title":"Eur J Rheumatol Inflamm"},{"key":"key\n\t\t\t\t20170522164359_keu424-B44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.1780220420","article-title":"Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis","volume":"22","author":"Weiner","year":"1979","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B45","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/kem090","article-title":"Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout","volume":"46","author":"Willburger","year":"2007","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170522164359_keu424-B46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF02836525","article-title":"Comparative study on treatment of acute gouty arthritis by electroacupuncture with different frequency","volume":"12","author":"Zou","year":"2006","journal-title":"Chin J Integr Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1071\/HC09315","article-title":"More allopurinol is needed to get gout patients < 0.36 mmol\/l: a gout audit in the form of a before\u2013after trial","volume":"1","author":"Arroll","year":"2009","journal-title":"J Prim Health Care"},{"key":"key\n\t\t\t\t20170522164359_keu424-B48","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: a twenty-eight day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose\u2013response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B50","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.080814","article-title":"Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout","volume":"36","author":"Becker","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B51","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.41.1.59","article-title":"Allopurinol treatment and its effect on renal function in gout: a controlled study","volume":"41","author":"Gibson","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B53","first-page":"104","article-title":"Different duration of colchicine for preventing recurrence of gouty arthritis","volume":"11","author":"Karimzadeh","year":"2006","journal-title":"J Res Med Sci"},{"key":"key\n\t\t\t\t20170522164359_keu424-B54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00315283","article-title":"The effect of benzbromarone on allopurinol\/oxypurinol kinetics in patients with gout","volume":"44","author":"Muller","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B55","first-page":"21","article-title":"Effects of allopurinol and benzbromarone on renal clearance of creatinine and uric acid in gouty patients","volume":"3","author":"Ohue","year":"1991","journal-title":"Jpn J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","article-title":"Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study","volume":"5","author":"Perez-Ruiz","year":"1999","journal-title":"J Clin Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.1780170517","article-title":"Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients","volume":"17","author":"Paulus","year":"1974","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4615-2584-4_12","article-title":"Free oxypurines in plasma and urine of gout patients before and after a purine-free diet","volume":"370","author":"Porcelli","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B59","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/ard.2008.091462","article-title":"A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300\u2013600 mg\/day versus benzbromarone 100\u2013200 mg\/day in patients with gout","volume":"68","author":"Reinders","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","article-title":"Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol","volume":"68","author":"Reinders","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B61","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1975.03240230017012","article-title":"Allopurinol and gouty hyperuricaemia: efficacy of a single daily dose","volume":"231","author":"Rodnan","year":"1975","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522164359_keu424-B62","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B63","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/art.33412","article-title":"Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy","volume":"64","author":"Schumacher","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.25.Suppl_6.623","article-title":"Comparison of allopurinol and probenecid","volume":"25","author":"Scott","year":"1966","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522164359_keu424-B66","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.23810","article-title":"Reduction of plasma urate levels following treatment with multiple doses of pegloticase in patients with treatment-failure gout","volume":"58","author":"Sundy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B67","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.30119","article-title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","volume":"63","author":"Stamp","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B68","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/ard.62.6.572","article-title":"Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and\/or losartan on uric acid metabolism","volume":"62","author":"Takahashi","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cccn.2003.09.019","article-title":"Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy","volume":"339","author":"Tsutsumi","year":"2004","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170522164359_keu424-B70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12020-011-9449-2","article-title":"Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese","volume":"40","author":"Wang","year":"2011","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t20170522164359_keu424-B71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11655-008-0103-7","article-title":"Clinical effect and action mechanism of Weicao Capsule in treating gout","volume":"14","author":"Song","year":"2008","journal-title":"Chin J Integr Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B72","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","article-title":"Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial","volume":"125","author":"Taylor","year":"2012","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170522164359_keu424-B73","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2011-200156","article-title":"Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial","volume":"71","author":"Dalbeth","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522164359_keu424-B74","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/acr.21690","article-title":"Rilonacept (Interleukin-1 Trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study","volume":"64","author":"Schumacher","year":"2012","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t20170522164359_keu424-B75","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3899\/jrheum.110916","article-title":"Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial","volume":"39","author":"Schumacher","year":"2012","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B76","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.22403","article-title":"Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxydase in patients with refractory gout","volume":"56","author":"Sundy","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B77","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/kem178","article-title":"Assessment of outcome in clinical trials of gout\u2014a review of current measures","volume":"46","author":"Taylor","year":"2007","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170522164359_keu424-B78","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","author":"Clarke","year":"2007","journal-title":"Trials"},{"key":"key\n\t\t\t\t20170522164359_keu424-B79","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522164359_keu424-B80","first-page":"1003","article-title":"Ankylosing Spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B81","first-page":"945","article-title":"Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the Ankylosing Spondylitis Module of OMERACT IV","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B82","first-page":"951","article-title":"Selection of instruments in the core set for DC-ART, SMARD, Physical Therapy and Clinical Record Keeping in ankylosing spondylitis. Progress Report of the ASAS Working Group","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B83","article-title":"Concept paper on the need of the guideline on clinical investigation of medicinal products for the treatment of gout","author":"European Medicines Agency","year":"2012"},{"key":"key\n\t\t\t\t20170522164359_keu424-B84","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3899\/jrheum.110271","article-title":"Patient-reported outcomes in chronic gout: a report from OMERACT 10","volume":"38","author":"Singh","year":"2011","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170522164359_keu424-B85","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","article-title":"Health-related quality of life in gout: a systematic review","volume":"52","author":"Chandratre","year":"2013","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170522164359_keu424-B86","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.22891","article-title":"Validation of a radiological damage index in chronic gout","volume":"57","author":"Dalbeth","year":"2007","journal-title":"Arthritis Care Res"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/54\/6\/981\/17389310\/keu424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T12:24:18Z","timestamp":1566044658000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/keu424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":86,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,11,13]]},"published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keu424","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,13]]}}}